Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Clinical Neuroscience has been awarded the Athena Swan Bronze Award for its efforts to improve the representation of women in science through its internal initiatives. The Athena Swan initiative in NDCN is being led by Professor Heidi Johansen-Berg and Dr Helen Higham.

Bronze Award holders must:

  • Demonstrate particular challenges and plan activities for the future.
  • Use quantitative and qualitative assessment to identify challenges and opportunities.
  • Have a plan that builds on this assessment, and lessons from any activities already in place.

The April 2012 award round was the biggest Athena SWAN has ever had with 96 award submissions and 14 panels. The Athena SWAN Charter evolved from work between the Athena Project and the Scientific Women’s Academic Network (SWAN), to advance the representation of women in science, engineering and technology.

For more information please visit the Athena Swan website.

Similar stories

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.

Multiple heart-related conditions linked to triple dementia risk, regardless of genetics

Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.

NDCN research presented at Myasthenia Gravis conference

The 14th Quinquennial Myasthenia Gravis Federation of America International Conference was recently held in Miami with 450 delegates attending in person, including over 100 from industry.